Strategic Considerations in ACT Manufacturing (“From Here to There, and Back Again”)

Advanced Therapeutics
Wednesday, May 6, 2020 | 3:00 – 4:15 pm


  • Steven A. Feldman, PhD, Director, Manufacturing and Process Development, Center for Cancer Cell Therapy, Stanford Cancer Institute/ Stanford School of Medicine


  • Eytan Abraham, Head of Personalized Medicine, Lonza Pharma & Biotech
  • Kim Nguyen, PhD, VP, CMC, Precision BioSciences, Inc